JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRAYER, O.
Right arrow Articles by MENDEZ, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KRAYER, O.
Right arrow Articles by MENDEZ, R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 82, Issue 2, 167-186, 1944
Copyright © 1944 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON VERATRUM ALKALOIDS

VI. PROTOVERATRINE: ITS COMPARATIVE TOXICITY AND ITS CIRCULATORY ACTION

OTTO KRAYER 1, GORDON K. MOE 1, and RAFAEL MENDEZ 1

1 From the Department of Pharmacology, Harvard Medical School, Boston

In acute toxicity experiments in mice with intravenous administration, protoveratrine, a triacyl ester of protoverine, was found to be ten times more toxic than veratridine, a monoacyl ester of cevine. The alkamines jervine, rubijervine, cevine, germine, and protoverine were very much less toxic than the ester alkaloids. Conspicuous qualitative differences exist between the alkaloids and the alkamines as groups as well as between the individual members of the two groups.

In conformity with its sterol nature and chemical relation to the cardiac glycosides, protoveratrine causes a systolic standstill in the isolated frog heart and positive inotropic (therapeutic) effect in the hypodynamic frog heart, as well as in the isolated failing mammalian heart. The minimal effective therapeutic dose is somewhat smaller than that of veratridine. The minimal toxic dose leading to irregularities of the heart rate is very much smaller than that of veratridine. Effective inotropic doses of protoveratrine not leading to irregularities of rate do not decrease the heart rate of the denervated heart; this is contrary to what was observed with veratridine. In the innervated heart, however, decrease in heart rate is produced which is partly due to reflex action and partly due to central action, as was observed with veratridine.

In the intact circulation of the dog the outstanding effect of small dosages (0.5 to 2.5 micrograms per kgm.) is a blood pressure decrease which is due in part to a heart rate decrease and in part to a decrease in arterial resistance.

The vasodilatation as studied in the femoral artery is reflex in nature, intraarterial injections of dosages leading to much higher arterial concentrations than would ever occur with intravenous administration having no effect.

As was observed with veratridine, large dosages of protoveratrine cause release of epinephrine from the suprarenal gland, which is an important element in the vasopressor effect.

Tachyphylaxis to the cardiodecelerator effect as well as to the depressor effect develops much more readily with protoveratrine than with veratridine.

Submitted on August 5, 1944




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. H. Bergel and G. S. Makin
Central and Peripheral Cardiovascular Changes Following Chemical Stimulation of the Surface of the Dog's Heart
Cardiovasc Res, January 1, 1967; 1(1): 80 - 90.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
A. D. Bender
The Hemodynamics of Hypertension and Anti Hypertensive Therapy
Angiology, September 1, 1966; 17(9): 627 - 639.
[PDF]


Home page
Arch Intern MedHome page
L. C. MILLS and J. H. MOYER
TREATMENT OF HYPERTENSION WITH ORALLY AND PARENTERALLY ADMINISTERED PURIFIED EXTRACTS OF VERATRUM VIRIDE: Comparison with Ganglionic (Hexamethonium) and Adrenergic Blocking Agents
Arch Intern Med, November 1, 1952; 90(5): 587 - 601.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1944 by the American Society for Pharmacology and Experimental Therapeutics.